Antibiotic use in EU
This article was originally published in The Tan Sheet
Executive Summary
More than 15 percent of antibiotic sales in Greece are OTC, according to a European Commission report in the April 19 British Medical Journal. The assessment of EU governments' strategies to reduce antimicrobial use found nonprescription antibiotics account for between 5 percent and 10 percent of total antibiotic sales in Malta, Romania and Spain. The report also found that 11 countries indicated all antibiotics were prescription, while seven, including the U.K., reported that nonprescription antibiotics accounted for less than 1 percent of their use. Fifteen EU member states have strategies on the prudent use of antimicrobials, eight are preparing them and four have no plans, the report found. Another pan-European survey indicated the message about overuse of antibiotics is not getting through to the public; although 37 percent of those surveyed received information within the previous year on the subject, only a fifth were aware that the drugs do not kill viruses or treat colds and the flu
You may also be interested in...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.